Boligra-HZ 25 Tablet
By Boligra-HZ
Rx
10 Tablet in a Strip

Composition
Hydroxyzine(25mg)

Manufacturer - Bolivian Healthcare
Colony, Aligarh Rd, Near Dev Hospital, Indra Nagar, Khandari Garhi, Hathras, Uttar Pradesh 204101

Expires on or after
September, 2025

liver
When using Boligra-HZ 25 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments in the dosage of Boligra-HZ 25 Tablet. It is recommended to consult with your doctor regarding the use of this medication to ensure safety and efficacy.

kidney
Boligra-HZ 25 Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. Consult your doctor before use.

alcohol
When using Boligra-HZ 25 Tablet, be cautious of excessive drowsiness when consuming alcohol.

driving
When using Boligra-HZ 25 Tablet, be cautious while driving as it can reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms.

pregnancy
It is better to consult your doctor before using Boligra-HZ 25 Tablet during pregnancy, as specific information about its safety during this time is not available.

breastfeeding
Boligra-HZ 25 Tablet is likely safe during breastfeeding, as per limited data. However, larger doses or prolonged use may lead to baby drowsiness and other effects.
Habit Forming | No |
Chemical Class | Piperazine Derivative |
Therapeutic Class | RESPIRATORY |
Action Class | H1 Antihistaminics (First Generation) |
₹37
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024